Glenmark Pharma net profit doubled to Rs 340 crore crore in Q1FY25 led by robust sales growth in India and Europe and reduction in finance, depreciation and ammortisation costs.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
